AFFY  Affymax Inc.

Exchange

NASDAQ

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

6.4M

Current Price

$0.17
+0.012 (+7.59%)

Book Price

$-0.27
Overvalued by 257.19%
Financial Institution

Company Metrics

  • 1.93 P/E
  • 141.04 P/S
  • 1.14 P/B
  • 0.082 EPS
  • 0.00 / N/A % Dividend
  • 462,636.00 Avg. Vol.
  • 37.65M Shares
  • 6.4M Market Cap.

Company Description

Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. The company is developing Hematide, which is in Phase III clinical trials for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood ...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Stocks Buzz – Affymax, Inc. (OTCMKTS:AFFY), Nuvilex, Inc. (OTCQB: NVLX ...
Techsonian (press release) - Sep 1, 2014
Manhattan, NY- September 01, 2014 - (Techsonian) - Affymax, Inc. (OTCMKTS:AFFY) reported financial results for the second quarter ending June 30, 2014.
Mid-Day Buzzers – Affymax, Inc. (OTCMKTS:AFFY),Nuvilex Inc (OTCMKTS ...
Techsonian (press release) - Aug 26, 2014
Birmingham, West Midlands - (TechSonian) - 08/26/2014 —Affymax, Inc. (OTCMKTS:AFFY) reported financial results for the second quarter ending June 30, 2014.
Intraday Movers - LOMIKO METALS INC (LMRMF), Discovery Minerals Ltd ...
Techsonian (press release) - Aug 30, 2014
LOMIKO METALS INC (OTCMKTS:LMRMF)advised that it was served with a Notice of Civil Claim by Alpha Capital Anstalt (“Alpha Capital”) filed in the Supreme Court of British Columbia on August 6, 2014.
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed ...
Business Wire (press release) - Sep 12, 2014
TO: ALL PERSONS AND ENTITIES THAT PURCHASED AFFYMAX, INC., (“AFFYMAX”) COMMON STOCK DURING THE PERIOD FROM AUGUST 8, 2012 THROUGH FEBRUARY 22, 2013, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”).
Xstelos Announces Intention To Vote Against Affymax's Plan Of Liquidation At ...
Stockhouse - Sep 19, 2014
NEW YORK, Sept. 19, 2014 /PRNewswire/ -- Xstelos Holdings, Inc. and the members of its Schedule 13D group (collectively, the "Xstelos Group" or "we") own approximately 5.0% of the outstanding shares of common stock of Affymax, Inc. (OTC: AFFY) ...
Stocks on the Run - Affymax, (OTCMKTS:AFFY),Nano Labs, (OTCMKTS:CTLE ...
Techsonian (press release) - Aug 27, 2014
Birmingham, West Midlands - (TechSonian) - 27 August 2014 - Affymax, (OTCMKTS:AFFY), a biopharmaceutical company, reported that its Board of Directors has approved the liquidation and dissolution of the company, subject to stockholder approval, ...
Lucrative Penny Stocks -Marina Biotech, Inc. (MRNA), ATHABASCA MINERALS ...
Techsonian (press release) - Aug 27, 2014
Las Vegas, NV - 27 August, 2014 - (TechSonian) –EquityObserver.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter ...
An Analysis Of Amgen
Seeking Alpha (registration) - Aug 22, 2014
A protein-based competitor to Epogen, Omontys, from Takeda (OTCPK:TKPYY) and Affymax (OTCQB:AFFY), came to market in 2012 and after killing a few people due to severe allergic reactions, was withdrawn last year.
Stocks Trending Alert – Elray Resources, (OTCMKTS:ELRA), Affymax ...
Techsonian (press release) - Aug 30, 2014
Birmingham, West Midlands - - Aug 30, 2014– (TechSonian) –Elray Resources, (ELRA), reported that it has Entered into a Definitive Stock Purchase Agreement.
Penny Stocks on the Run - Tauriga Sciences Inc (TAUG), Neutra Corp (NTRR ...
Techsonian (press release) - Sep 1, 2014
Las Vegas, NV - 1st September, 2014– (TechSonian) –Tauriga Sciences Inc (OTCMKTS:TAUG) proclaimed that it has arrived into an investment banking agreement with Tokyo, Japan based investment banking firm Dragoon Capital, Inc. (“Dragoon”).